PriceTargets.com logo

Circassia Group - CIR Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0 As of 09/2/2022 08:40 PM ET
+0 (0.00%)

This chart shows the closing price for CIR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Circassia Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CIR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CIR

Analyst Price Target is GBX 0
This price target is based on 0 analysts offering 12 month price targets for Circassia Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a NaN upside from the last price of GBX 0.

This chart shows the closing price for CIR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Circassia Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/26/2021Peel HuntReiterated RatingUnder Review
5/26/2021Peel HuntReiterated RatingUnder review
6/16/2020Peel HuntReiterated RatingUnder Review
6/16/2020FinnCapReiterated RatingCorporate
6/2/2020Peel HuntReiterated RatingUnder Review
5/28/2020FinnCapReiterated RatingCorporate
5/1/2020Peel HuntReiterated RatingUnder Review
4/24/2020Peel HuntReiterated RatingUnder Review
4/17/2020FinnCapReiterated RatingCorporate
4/7/2020Peel HuntReiterated RatingBuy
3/5/2020Peel HuntReiterated RatingBuy
2/13/2020Peel HuntReiterated RatingBuy
2/5/2020Peel HuntReiterated RatingBuy
1/27/2020Peel HuntReiterated RatingBuy
1/9/2020Peel HuntReiterated RatingBuy
1/9/2020FinnCapReiterated RatingCorporate
(Data available from 12/26/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Circassia Group logo
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 34
Low: 34
High: 34

52 Week Range

Now: N/A

Volume

4,513 shs

Average Volume

773,465 shs

Market Capitalization

£142.66 million

P/E Ratio

3,400.00

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Circassia Group?

The following Wall Street analysts have issued stock ratings on Circassia Group in the last twelve months:
View the latest analyst ratings for CIR.

What is the current price target for Circassia Group?

0 Wall Street analysts have set twelve-month price targets for Circassia Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Circassia Group in the next year.
View the latest price targets for CIR.

What is the current consensus analyst rating for Circassia Group?

Circassia Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CIR.

What other companies compete with Circassia Group?

Other companies that are similar to Circassia Group include Silence Therapeutics, Oxford Biomedica, PureTech Health, Horizon Discovery Group plc (HZD.L) and Verona Pharma plc (VRP.L). Learn More about companies similar to Circassia Group.

How do I contact Circassia Group's investor relations team?

Circassia Group's physical mailing address is 30 Corporate Dr., Suite 200, Burlington, Massachusetts 01803-4238. The company's listed phone number is 44 1865 405 560. The official website for Circassia Group is www.circassia.co.uk. Learn More about contacing Circassia Group investor relations.